Efficacy & Safety of Oral AMN107 in Adults With Chronic Myelogenous

See also
Status	Clinical Trial	Phase
Terminated	`NCT00393380` - Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor	Phase 2
Completed	`NCT00186342` - Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies	N/A
Completed	`NCT00759837` - Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects	Phase 1
Completed	`NCT00538109` - An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase	N/A
Completed	`NCT00040105` - Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia	Phase 1
Terminated	`NCT00176930` - Stem Cell Transplant for Hematological Malignancy	N/A
Recruiting	`NCT01015742` - Unrelated Double Umbilical Cord Blood Units Transplantation	Phase 2/Phase 3
Completed	`NCT00406393` - Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)	Phase 3
Completed	`NCT00246662` - Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies	Phase 1
Terminated	`NCT00306332` - T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation	Phase 3
Terminated	`NCT00058747` - AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™	Phase 2
Active, not recruiting	`NCT00538447` - Prospective Database for Chronic Myelogenous Leukemia	N/A
Terminated	`NCT01050946` - Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit	Phase 2
Completed	`NCT00034684` - Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)	Phase 1/Phase 2
Recruiting	`NCT04260022` - Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL	Phase 1
Terminated	`NCT00167180` - Post Transplant Donor Lymphocyte Infusion	Phase 2
Terminated	`NCT00449761` - Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase	Phase 2
Completed	`NCT00455221` - Safety Assessment of a Multipeptide-gene Vaccine in CML	Phase 1
Completed	`NCT00298987` - A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate	Phase 2
Completed	`NCT00763763` - Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive	Phase 2

NCT number	NCT00264160
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	May 2006
Completion date	August 2009

Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms